G1 Therapeutics, Inc.
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLIFERATION
Last updated:
Abstract:
This invention is in the area of heterocyclic-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
Status:
Application
Type:
Utility
Filling date:
1 Jul 2020
Issue date:
22 Oct 2020